Skip to main content

MoneyWorks4Me

Jubilant Ingrevia acquires 100% equity stake in Remidex Pharma

01 Apr 2026 Evaluate

Jubilant Ingrevia has acquired 100% equity stake in Remidex Pharma (Remidex) pursuant to the Share Purchase Agreement entered into with Remidex. 

This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4).

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Peers
Company Name CMP
Godrej Industries 1089.00
SRF 2509.10
BASF India 2905.85
Pidilite Inds. 1617.80
Tata Chemicals 639.15
View more..